Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.
When Trova Wine and Market shut its doors last month after nearly five years in business in Dallas, owner Michelle Bonds pointed to an unexpected reason for closure: GLP-1 weight loss drugs like ...
These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...
Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.
They also discovered that cigarette use declined among a subgroup of smokers in the study, lending weight to the hypothesis ...
Health and Me on MSN1d
GLP-1 Drugs Could Be Used To Treat Chronic Kidney DiseaseA latest research led by Dr Shuyao Zhang, an assistant professor of internal medicine at UT Southwestern in Dallas reveal the ...
1d
News Nation on MSNStudy finds rare vision issues in taking GLP-1 weight loss drugsAlthough reports of vision problems with weight loss drugs are still rare, researchers say there is cause for concern because ...
A small semaglutide trial suggests the medicine's suppression of appetite may extend to alcohol, but larger tests are needed ...
Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...
Obesity is an epidemic in the United States, but more people are shedding pounds with the help of weight loss drugs.
A majority with overweight/obesity discontinue within a year, but the rate is higher among those without type 2 diabetes.
The beverage giant is ready to manage, mitigate and adjust to the “dynamic macro environment,” including potential tariffs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results